Substituted tetralone derivatives for enhancing cognition
申请人:Merck Sharpe & Dohme Limited
公开号:US06156761A1
公开(公告)日:2000-12-05
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof: ##STR1## wherein A, B, R2, R3 and q are as defined in the disclosure, pharmaceutical compositions containing them; methods for their production; their use in therapy and methods of treatment of disease states where cognition enhancement is required, such as Alzheimer's disease.